Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03066050 · ClinicalTrials.gov registry record

Long Term Follow Up for CTSN Mitral Valve Repair Studies

A clinical trial of Coronary Artery Disease and Mitral Valve Insufficiency, sponsored by Icahn School of Medicine at Mount Sinai.

Active
Registry status
368
Enrollment target
20
Study locations

NCT03066050 is a study of Coronary Artery Disease and Mitral Valve Insufficiency that is active but no longer recruiting, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 368 participants, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (71% lower). The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03066050, a study of Coronary Artery Disease and Mitral Valve Insufficiency, is active but no longer recruiting, sponsored by Icahn School of Medicine at Mount Sinai.

ACTIVE NOT RECRUITING
Registry status
368 participants
Enrollment target
20
Study locations

Study Summary

This study is a continuation of two previous studies --- the Severe Ischemic Mitral Regurgitation (SMR) Trial (NCT00807040) and the Moderate Ischemic Mitral regurgitation (MMR) Trial (NCT00806988) --- to learn more about patients' health 5-10 years after their mitral valve surgeries. The investigators will collect long-term health information on SMR and MMR trial participants using electronic medical records, patient and/or family input, public records, and healthcare- and vital status-related databases.

Conditions Studied

Coronary Artery Disease Mitral Valve Insufficiency

Interventions

  • OTHER MV Repair
  • OTHER MV Replacement
  • OTHER CABG

Study Locations (20)

North Carolina

  • Mission Hospital - Asheville
  • Duke University - Durham
  • East Carolina Heart Institute - Greenville

Ontario

  • Sunnybrook Health Science Centre - Toronto
  • Saint Michael's Hospital - Toronto
  • Toronto General Hospital - Toronto

Maryland

  • University of Maryland - Baltimore
  • Suburban Hospital - Bethesda

New York

  • Columbia University Medical Center - New York
  • Montefiore Einstein Heart Center - The Bronx

Ohio

  • Cleveland Clinic Foundation - Cleveland
  • Ohio State University - Columbus

Virginia

  • University of Virginia Health Systems - Charlottesville
  • Inova Heart and Vascular Institute - Falls Church

California

  • University of Southern California - Los Angeles

Georgia

  • Emory University - Atlanta

Trial Details

FieldValue
Enrollment Target 368 participants
Start Date 2017-05-03
Est. Completion 2027-07-31

Sponsor

Icahn School of Medicine at Mount Sinai

708 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03066050

The ClinicalTrials.gov registry entry for NCT03066050 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 368 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (71% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 3 interventions - of which MV Repair is the first listed.

NCT03066050 reports 20 study locations spanning 12 distinct geographic areas - top geographies include North Carolina, Ontario, Maryland.

Frequently Asked Questions

What is clinical trial NCT03066050 about?

NCT03066050 is a clinical study titled "Long Term Follow Up for CTSN Mitral Valve Repair Studies". This study is a continuation of two previous studies --- the Severe Ischemic Mitral Regurgitation (SMR) Trial (NCT00807040) and the Moderate Ischemic Mitral regurgitation (MMR) Trial (NCT00806988) --- to learn more about patients' health 5-10 years after their mitral valve surgeries. The investigato...

What is the current status of trial NCT03066050?

This trial is currently active not recruiting. The enrollment target is 368 participants. The study started on 2017-05-03. Estimated completion is 2027-07-31.

What conditions does trial NCT03066050 study?

This clinical trial studies the following conditions: Coronary Artery Disease, Mitral Valve Insufficiency.

What interventions are being tested in trial NCT03066050?

The interventions under investigation include: MV Repair (OTHER), MV Replacement (OTHER), CABG (OTHER).

Who is sponsoring clinical trial NCT03066050?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03066050 being conducted?

This trial has 20 study locations across California, Georgia, Maryland, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Coronary Artery Disease

All registered trials for this condition

Mitral Valve Insufficiency

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.